437 related articles for article (PubMed ID: 27973438)
1. Pathophysiology of Non Alcoholic Fatty Liver Disease.
Petta S; Gastaldelli A; Rebelos E; Bugianesi E; Messa P; Miele L; Svegliati-Baroni G; Valenti L; Bonino F
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27973438
[TBL] [Abstract][Full Text] [Related]
2. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.
Koukias N; Buzzetti E; Tsochatzis EA
Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962
[TBL] [Abstract][Full Text] [Related]
3. The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial.
Razavi Zade M; Telkabadi MH; Bahmani F; Salehi B; Farshbaf S; Asemi Z
Liver Int; 2016 Apr; 36(4):563-71. PubMed ID: 26503843
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids and non-alcoholic fatty liver disease.
Woods CP; Hazlehurst JM; Tomlinson JW
J Steroid Biochem Mol Biol; 2015 Nov; 154():94-103. PubMed ID: 26241028
[TBL] [Abstract][Full Text] [Related]
5. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
[TBL] [Abstract][Full Text] [Related]
6. Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue.
Kim YJ; Choi JY; Ryu R; Lee J; Cho SJ; Kwon EY; Lee MK; Liu KH; Rina Y; Sung MK; Choi MS
Nutrients; 2016 Aug; 8(9):. PubMed ID: 27589792
[TBL] [Abstract][Full Text] [Related]
7. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
8. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
[TBL] [Abstract][Full Text] [Related]
9. [Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis].
Berlanga A; Guiu-Jurado E; Porras JA; Aragonès G; Auguet T
Clin Investig Arterioscler; 2016; 28(1):47-61. PubMed ID: 26049666
[TBL] [Abstract][Full Text] [Related]
10. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
[TBL] [Abstract][Full Text] [Related]
11. Effects of abomasal infusion of long-chain fatty acids on splanchnic metabolism of pancreatic and gut hormones in lactating dairy cows.
Benson JA; Reynolds CK
J Dairy Sci; 2001 Jun; 84(6):1488-500. PubMed ID: 11417709
[TBL] [Abstract][Full Text] [Related]
12. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
13. Role of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction.
Lopategi A; López-Vicario C; Alcaraz-Quiles J; García-Alonso V; Rius B; Titos E; Clària J
Mol Cell Endocrinol; 2016 Jan; 419():44-59. PubMed ID: 26433072
[TBL] [Abstract][Full Text] [Related]
14. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
[TBL] [Abstract][Full Text] [Related]
15. Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women.
Corbould A; Bhathal PS; Dixon JB; O'Brien PE
Metab Syndr Relat Disord; 2014 Aug; 12(6):311-9. PubMed ID: 24819229
[TBL] [Abstract][Full Text] [Related]
16. The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.
Saponaro C; Gaggini M; Carli F; Gastaldelli A
Nutrients; 2015 Nov; 7(11):9453-74. PubMed ID: 26580649
[TBL] [Abstract][Full Text] [Related]
17. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
Maximos M; Bril F; Portillo Sanchez P; Lomonaco R; Orsak B; Biernacki D; Suman A; Weber M; Cusi K
Hepatology; 2015 Jan; 61(1):153-60. PubMed ID: 25145475
[TBL] [Abstract][Full Text] [Related]
18. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
Abenavoli L; Milic N; Peta V; Alfieri F; De Lorenzo A; Bellentani S
World J Gastroenterol; 2014 Dec; 20(45):16831-40. PubMed ID: 25492997
[TBL] [Abstract][Full Text] [Related]
19. Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil.
Morrison MC; Mulder P; Stavro PM; Suárez M; Arola-Arnal A; van Duyvenvoorde W; Kooistra T; Wielinga PY; Kleemann R
PLoS One; 2015; 10(9):e0139196. PubMed ID: 26405765
[TBL] [Abstract][Full Text] [Related]
20. Effect of a high fat, high sucrose diet on the promotion of non-alcoholic fatty liver disease in male rats: the ameliorative role of three natural compounds.
Ragab SM; Abd Elghaffar SKh; El-Metwally TH; Badr G; Mahmoud MH; Omar HM
Lipids Health Dis; 2015 Jul; 14():83. PubMed ID: 26228038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
